The relative amount of mRNA of IL-6 in L-MDS patients was 2.4-(P<0.05) and 5.3-fold (P<0.001) of that in E-MDS patients and healthy controls, respectively (Fig. 4B). Here, IL6 is linked to myelodysplastic syndrome.